Introduced by Rep. Hank Vaupel R-Fowlerville on November 7, 2017
To impose a new mandate on manufacturers of prescription drugs that they must file detailed reports with a state agency on the costs associated with developing and marketing expensive prescription drugs. The bill would also create a state prescription drug advisory commission comprised of individuals representing specified interests to recommend policies to mitigate the expense incurred by state medical welfare programs in providing drugs to beneficiaries. Official Text and Analysis.
Referred to the House Health Policy Committee on November 7, 2017